| Name | Title | Contact Details |
|---|
PinnacleCare International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Baltimore, MD. To find more information about PinnacleCare International, please visit www.pinnaclecare.com
Jasper County Health Department is a Newton, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Swisslog Healthcare provides integrated medication supply chain solutions to hospitals and health systems to assist providers in treating patients across the continuum of care. Integrating transport and pharmacy automation, value-added services, and intelligent software, Swisslog Healthcare enables healthcare providers to respond to patients` needs quickly and with greater accuracy. The company minimizes many sources of operational waste, so providers achieve higher levels of productivity to impact the well-being of patients in positive ways.
At MELA Sciences, we design and develop innovative software-driven medical technologies for physician clinical use during the detection of skin cancers at the most curable and cost-effective stages. Our mission is to develop breakthrough medical technologies to improve skin cancer detection and achieve better outcomes for all. We envision a world in which our pioneering innovations will change the way patients think about skin cancer, while providing dermatologists and clinicians with new, effective, non-invasive tools for the earliest detection possible. MELA Sciences conducted the largest, positive prospective study ever done on the melanoma disease, and is the first and only medical technology company to receive both FDA Pre-Market Approval (PMA) for the U.S. and CE Marking certification for the European Union for a device of this nature. The company’s flagship product, MelaFind®, is intended to provide dermatologists with software-driven image analysis of clinically atypical pigmented skin lesions when they choose to obtain additional information to help decide whether to biopsy or not. The FDA has approved MELA Sciences’ MelaFind® Pre-Market Approval application for use in the United States and MELA Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.
Excelera is a national network of academic medical centers and integrated delivery networks with specialty pharmacy capabilities. Excelera supports its members by using sophisticated data management, reporting and analytical capabilities; secures access to limited distribution specialty pharmaceuticals; and provides clinical care protocols and best practices. Excelera is grounded in the simple premise that health systems, along with their specialist physicians, are best equipped to produce optimal health and financial outcomes for complex patients because they are the central hub for coordinating and integrating care needs, managing the electronic medical record, and providing a high-touch local service.